These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9860186)

  • 1. Interferon induction in turkeys by oral administration of the imidazoquinolinamine S-28828 and modulation of the pathogenesis of Escherichia coli.
    Rautenschlein S; Miller RL; Sharma JM
    Vet Immunol Immunopathol; 1998 Nov; 66(2):127-41. PubMed ID: 9860186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of the imidazoquinolinamine S-28828 on the pathogenesis of a type II adenovirus in turkeys.
    Rautenschlein S; Miller RL; Sharma JM
    Antiviral Res; 2000 Jun; 46(3):195-205. PubMed ID: 10867157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and In vitro interferon induction in chickens by S -28828, an imidazoquinolinamine immunoenhancer.
    Karaca K; Sharma JM; Tomai MA; Miller RL
    J Interferon Cytokine Res; 1996 Apr; 16(4):327-32. PubMed ID: 9162527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine induction in mice by the immunomodulator imiquimod.
    Reiter MJ; Testerman TL; Miller RL; Weeks CE; Tomai MA
    J Leukoc Biol; 1994 Feb; 55(2):234-40. PubMed ID: 7507969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of passive immunization on phagocytosis of blood-borne Escherichia coli in spleen and liver of turkeys.
    Arp LH
    Am J Vet Res; 1982 Jun; 43(6):1034-40. PubMed ID: 7049015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.
    Sidky YA; Borden EC; Weeks CE; Reiter MJ; Hatcher JF; Bryan GT
    Cancer Res; 1992 Jul; 52(13):3528-33. PubMed ID: 1377595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
    Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
    Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.
    Wagner TL; Horton VL; Carlson GL; Myhre PE; Gibson SJ; Imbertson LM; Tomai MA
    Cytokine; 1997 Nov; 9(11):837-45. PubMed ID: 9367544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of the systemic components of the chicken (Gallus gallus domesticus) immune system following activation by Escherichia coli; implications for the costs of immunity.
    Iseri VJ; Klasing KC
    Dev Comp Immunol; 2013; 40(3-4):248-57. PubMed ID: 23500513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of growth and E. coli endotoxaemia on amoxicillin pharmacokinetics in turkeys.
    Poźniak B; Pasławska U; Motykiewicz-Pers K; Świtała M
    Br Poult Sci; 2017 Aug; 58(4):462-468. PubMed ID: 28290713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma/delta T cell response of chickens after oral administration of attenuated and non-attenuated Salmonella typhimurium strains.
    Berndt A; Methner U
    Vet Immunol Immunopathol; 2001 Jan; 78(2):143-61. PubMed ID: 11182154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of blood-borne Escherichia coli with phagocytes of spleen and liver in turkeys.
    Arp LH; Cheville NF
    Am J Vet Res; 1981 Apr; 42(4):650-7. PubMed ID: 7036803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming.
    Marien M; Decostere A; Duchateau L; Chiers K; Froyman R; Nauwynck H
    Vet Microbiol; 2007 Mar; 121(1-2):94-104. PubMed ID: 17187945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of water supplementation with vitamin E and sodium salicylate (Uni-Sol) on the resistance of turkeys to Escherichia coli respiratory infection.
    Huff GR; Huff WE; Balog JM; Rath NC; Izard RS
    Avian Dis; 2004; 48(2):324-31. PubMed ID: 15283419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum resistance and virulence of Escherichia coli isolated from turkeys.
    Ellis MG; Arp LH; Lamont SJ
    Am J Vet Res; 1988 Dec; 49(12):2034-7. PubMed ID: 3071193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood.
    Rönnblom L; Forsgren A; Alm GV
    Infect Immun; 1983 Apr; 40(1):126-32. PubMed ID: 6403464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spray Escherichia coli vaccine on the immunity of poultry.
    Fernandes Filho T; Fávaro C; Ingberman M; Beirão BC; Inoue A; Gomes L; Caron LF
    Avian Dis; 2013 Sep; 57(3):671-6. PubMed ID: 24283136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the resistance of turkeys to Escherichia coli challenge after immunosuppression with dexamethasone.
    Huff GR; Huff WE; Balog JM; Rath NC
    Poult Sci; 1999 Jan; 78(1):38-44. PubMed ID: 10023744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.